The clinical utility of subcutaneous ... bind to both the catalytic site and the exosite of thrombin to exert their inhibitory effects on thrombin. Unfractionated heparin (UF) and low-molecular ...
The pharmacodynamics of tinzaparin 4500 IU s.c. (treatment E) and s.c. heparin (treatment A ... (mostly occurring at the injection site), injection-site reactions in 17 subjects (57%) (due ...
It is a low molecular weight heparin ... It is given as subcutaneous (into the fatty layer of skin) or intravenous (into the vein) injection. For preventing DVT in abdominal surgery, it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback